305 related articles for article (PubMed ID: 16866910)
21. Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid.
Leoni V; Caccia C
Biochem Pharmacol; 2013 Jul; 86(1):26-36. PubMed ID: 23541982
[TBL] [Abstract][Full Text] [Related]
22. Increased Levels of 27-Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats.
Zhang X; Lv C; An Y; Liu Q; Rong H; Tao L; Wang Y; Wang Y; Xiao R
Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29193679
[TBL] [Abstract][Full Text] [Related]
23. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
[TBL] [Abstract][Full Text] [Related]
24. 24S-hydroxycholesterol: Cellular effects and variations in brain diseases.
Sodero AO
J Neurochem; 2021 May; 157(4):899-918. PubMed ID: 33118626
[TBL] [Abstract][Full Text] [Related]
25. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain.
Locatelli S; Lütjohann D; Schmidt HH; Otto C; Beisiegel U; von Bergmann K
Arch Neurol; 2002 Feb; 59(2):213-6. PubMed ID: 11843691
[TBL] [Abstract][Full Text] [Related]
26. Five decades with oxysterols.
Björkhem I
Biochimie; 2013 Mar; 95(3):448-54. PubMed ID: 23111110
[TBL] [Abstract][Full Text] [Related]
27. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation.
Shafaati M; Marutle A; Pettersson H; Lövgren-Sandblom A; Olin M; Pikuleva I; Winblad B; Nordberg A; Björkhem I
J Lipid Res; 2011 May; 52(5):1004-10. PubMed ID: 21335619
[TBL] [Abstract][Full Text] [Related]
28. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Rao ML; Maier W; Björkhem I; von Bergmann K; Heun R
Neuroreport; 2000 Jun; 11(9):1959-62. PubMed ID: 10884051
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease.
Mateos L; Ismail MA; Gil-Bea FJ; Leoni V; Winblad B; Björkhem I; Cedazo-Mínguez A
J Alzheimers Dis; 2011; 24(4):669-79. PubMed ID: 21297254
[TBL] [Abstract][Full Text] [Related]
30. Statins: drugs for Alzheimer's disease?
Eckert GP; Wood WG; Müller WE
J Neural Transm (Vienna); 2005 Aug; 112(8):1057-71. PubMed ID: 15682268
[TBL] [Abstract][Full Text] [Related]
31. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?
Holdenrieder S; Lütjohann D; Geiger S; von Bergmann K; Stieber P; Hamann GF
Neurosci Lett; 2004 Sep; 368(2):201-4. PubMed ID: 15351449
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
[TBL] [Abstract][Full Text] [Related]
33. Oxysterols as markers of neurological disease--a review.
Leoni V
Scand J Clin Lab Invest; 2009; 69(1):22-5. PubMed ID: 19199127
[TBL] [Abstract][Full Text] [Related]
34. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism.
Mateos L; Ismail MA; Gil-Bea FJ; Schüle R; Schöls L; Heverin M; Folkesson R; Björkhem I; Cedazo-Mínguez A
J Biol Chem; 2011 Jul; 286(29):25574-85. PubMed ID: 21628469
[TBL] [Abstract][Full Text] [Related]
35. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
[TBL] [Abstract][Full Text] [Related]
36. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
[TBL] [Abstract][Full Text] [Related]
37. Brain-to-blood elimination of 24S-hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood-brain barrier.
Ohtsuki S; Ito S; Matsuda A; Hori S; Abe T; Terasaki T
J Neurochem; 2007 Nov; 103(4):1430-8. PubMed ID: 17868302
[TBL] [Abstract][Full Text] [Related]
38. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.
Sauder S; Kölsch H; Lütjohann D; Schulz A; von Bergmann K; Maier W; Heun R
J Neural Transm (Vienna); 2005 Oct; 112(10):1381-9. PubMed ID: 15666037
[TBL] [Abstract][Full Text] [Related]
39. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans.
Bjorkhem I; Andersson U; Ellis E; Alvelius G; Ellegard L; Diczfalusy U; Sjovall J; Einarsson C
J Biol Chem; 2001 Oct; 276(40):37004-10. PubMed ID: 11463788
[TBL] [Abstract][Full Text] [Related]
40. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
